A clinical study to evaluate the efficacy and safety of cyclosporine (CsA) and sirolimus (SRL) induction followed by cyclosporine withdrawal in Korean renal allograft recipients.

Trial Profile

A clinical study to evaluate the efficacy and safety of cyclosporine (CsA) and sirolimus (SRL) induction followed by cyclosporine withdrawal in Korean renal allograft recipients.

Completed
Phase of Trial: Phase III

Latest Information Update: 04 May 2010

At a glance

  • Drugs Ciclosporin; Sirolimus
  • Indications Renal transplant rejection
  • Focus Therapeutic Use
  • Sponsors Wyeth
  • Most Recent Events

    • 12 Jan 2010 Actual patient number (79) added as reported by ClinicalTrials.gov.
    • 02 Dec 2008 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 24 Jan 2008 The expected completion date for this trial is now 1 Nov 2008.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top